Log In
Print
BCIQ
Print
Print this Print this
 

NS3 protease inhibitor

  Manage Alerts
Collapse Summary General Information
Company Medivir AB
DescriptionNS3 protease inhibitor
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationDengue fever
Indication DetailsTreat Dengue fever
Regulatory Designation

Partner

Johnson & Johnson


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today